Brothers Leverage AI to Launch Medvi into $1.8 Billion Telehealth Powerhouse with Just Two Employees

By Staff Reporter | April 3, 2026

In a stunning testament to the transformative power of artificial intelligence, brothers Matthew and his sibling have built Medvi, a telehealth startup specializing in GLP-1 weight-loss drugs, into a projected $1.8 billion company with only two employees.[4][5]

Matthew Gallagher launched Medvi in just two months using a modest $20,000 investment and over a dozen AI tools, bypassing traditional development hurdles to create a sleek website and user interface tailored to a market desperate for accessible weight-loss solutions.[1][4]

Rapid Growth in a High-Demand Sector

Medvi tapped into the booming demand for GLP-1 drugs, such as those popularized by brands like Ozempic and Wegovy, where patients face long wait times and high costs through conventional channels. By end of last year, the company had achieved $401 million in annual sales, serving 250,000 customers with a robust 16.2% net profit margin—totaling $65 million after expenses on telehealth platforms, marketing, and software.[1][4]

This outperforms competitors like Hims, which reported a 5.5% net profit in the same period, highlighting Medvi’s lean operation and AI-driven efficiency.[1]

AI as the Secret Weapon

Gallagher’s approach exemplifies “vibe coding,” where AI handles much of the heavy lifting in software development, allowing non-technical founders to build sophisticated platforms rapidly. He utilized AI for everything from coding the backend to designing the frontend and automating customer interactions.[5]

“He basically chose a sector where customers are desperate, slapped a website and an interface for connecting with a drug,” noted observers on Hacker News, underscoring the simplicity and effectiveness of the strategy.[1]

This model contrasts with labor-intensive startups, proving that in the AI era, minimal teams can scale massively by leveraging tools for automation, personalization, and operations.

Broader Implications for Entrepreneurship

Medvi’s success story echoes trends in other AI ventures. For instance, Higgsfield AI reached $200 million in annual recurring revenue in nine months through daily shipping of product updates and laser-focused customer feedback from just eight users.[2]

Similarly, Legora, a legal AI firm led by CEO Max Junestrand, is redefining law firm workflows with tools for document review and drafting, riding the post-GPT wave.[3]

These cases illustrate a shift: founders are targeting niche, painful problems in underserved industries rather than broad markets. Gallagher’s focus on weight-loss telehealth—amid FDA scrutiny and supply shortages—positioned Medvi perfectly.[1]

“We were iterating every day… trying to find workflows that matter.”
– Insights from similar AI builders[2]

Challenges and Future Outlook

While Medvi tracks for $1.8 billion in 2026 sales, the telehealth space faces regulatory hurdles, including FDA compliance for compounded drugs and competition from giants like Eli Lilly and Novo Nordisk.[1]

Critics question scalability with such a small team, but Gallagher’s use of AI for trust-building elements—like secure prescribing and patient monitoring—addresses key bottlenecks in the industry.[5]

Experts predict this lean AI model will inspire a wave of solo or micro-team startups in healthcare, finance, and beyond, democratizing access to billion-dollar opportunities.

Lessons for Aspiring Founders

• Pick desperate markets: Weight-loss drugs saw explosive demand post-pandemic.
• AI-first build: Use tools to launch in weeks, not years.
• Customer obsession: Tight feedback loops drive product-market fit.
• Daily iteration: Ship updates relentlessly to adapt to AI advancements.

As AI lowers barriers to entry, stories like Medvi signal a new era where two brothers can rival corporate behemoths. Gallagher’s journey from idea to empire underscores that in 2026, the real currency is not capital or headcount, but clever AI application.

This article synthesizes reports from The New York Times, Techmeme, Hacker News, and industry analyses.